Shreveport, LA (PRWEB) May 18, 2007 -- Embera NeuroTherapeutics, Inc. announced today that Charles O’Brien, MD, Phd, Kathleen Brady, MD, PhD and Rajita Sinha, PhD have joined the company’s Scientific Advisory Board. Dr. Nicholas E. Goeders, Embera Chief Scientific Officer, said “It is exciting to have these three experts in the field of addiction research as members of our Scientific Advisory Board. Their vast knowledge and experience will be invaluable in the design and execution of our clinical trials on addiction.”
